Psychedelic-Assisted Psychotherapy and Post-Traumatic Stress Disorder

Join this FREE, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

Interview with Professor Rachel Yehuda PhD (USA)
Professor of Psychiatry and Neuroscience, Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine

PTSD is a disorder that is becoming more prevalent in our society and is very difficult to treat. Most of the currently used psychotherapies for the treatment of PTSD are exposure-based therapies, which rely on imaginal visualization of the traumatic events and exposure to trauma-related cues that trigger fear responses. The role of the therapists is to instruct the patient to relive the trauma and to provide a cognitive framework for change. For some patients this is difficult, leading to non-response or treatment dropout. Engagement in psychotrauma focused therapy may be difficult for some patients, especially in cases of extreme affect dysregulation, shame or guilt associated with the recall of traumatic memories.

There is an urgent need for new treatments for PTSD for this group of patients. The use of psychedelic-assisted therapies, in particular MDMA-assisted therapy is offering opportunities to support critical aspects of the psychotherapeutic process. In this webinar elements of PTSD, its neuroscience, history and exploration of the landscape towards MDMA and other psychedelics will be discussed.